This consensus statement aims to ensure equitable access to care for human epidermal growth factor receptor 2-negative metastatic BC (HR+/HER2- mBC) and triple-negative mBC (mTNBC) in Romania. The gene discussed is ERBB2; the disease is breast cancer.